Raymond James Financial Inc Pro Qr Therapeutics N.V. Transaction History
Raymond James Financial Inc
- $299 Billion
- Q3 2025
A detailed history of Raymond James Financial Inc transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Raymond James Financial Inc holds 110,270 shares of PRQR stock, worth $241,491. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110,270
Previous 95,721
15.2%
Holding current value
$241,491
Previous $195,000
18.97%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PRQR
# of Institutions
65Shares Held
38.3MCall Options Held
0Put Options Held
0-
Adage Capital Partners Gp, L.L.C. Boston, MA6.25MShares$13.7 Million0.02% of portfolio
-
Privium Fund Management B.V.5MShares$10.9 Million1.92% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.6MShares$7.88 Million0.88% of portfolio
-
Morgan Stanley New York, NY2.9MShares$6.35 Million0.0% of portfolio
-
Abrdn PLC2.3MShares$5.03 Million0.01% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $156M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...